erative anticoagulation. No patient underwent a second-look operation. The postoperative morbidity and mortality rates were 55% and 11%, respectively.
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Cost-Effectiveness of Current and Emerging Treatments of Varicose Veins
Objectives: Over the past decade, the treatment of varicose veins has changed dramatically with the increasing use of endovenous ablation, which has now become the new gold standard. Novel, nonthermal methods have also recently been introduced and are competing with the more traditional endothermal technologies. However, evidence of the cost-effectiveness of these newer methods is lacking. Therefore, the cost-effectiveness of current technologies, including conservative care (CONS), surgery (HL/S), ultrasound-guided foam sclerotherapy (UGFS), endovenous laser ablation (EVLA), and radiofrequency ablation (RFA), and emerging technologies, including mechanochemical ablation (MOCA) and cyanoacrylate glue occlusion (CAE). For treatment of varicose veins over 5 years was analyzed.
Methods: A decision model was constructed. Effectiveness was measured by re-intervention on the truncal vein, re-treatment of residual varicosities and quality-adjusted life years over 5 years. Costs were estimated from systematic review, National Health Service unit costs, and manufacturer's list prices. Sensitivity analysis and probabilistic sensitivity analysis was carried out.
Results: At 5 years, CONS has the lowest overall cost and quality of life per person over 5 years; HL/S, EVLA, RFA, and MOCA have similar costs and effectiveness; and CAE has the highest overall cost but is no more effective than other therapies.
Conclusions: At a threshold of £20,000/ quality-adjusted life years, as used in the United Kingdom, the probabilities of treatment being costeffective over 5 years are: EVLA, 0.316; RFA, 0.265; UGFS, 0.136; MOCA, 0.111; CONS, 0.170; HL/S, 0.002; and CAE, 0.000. Further evidence on the effectiveness and health-related quality of life associated with MOCA and CAE are needed. 
Abbott Northwestern Hospital
Objectives: May-Thurner syndrome (MTS) with associated phlegmasia cerulea dolens (PLD) causing acute left iliac vein rupture is rarely reported in the literature, with <50 cases of spontaneous iliac vein rupture (SIVR) described and one-third associated with MTS.
Methods: We present the largest United States-based case series of three patients with MTS and SIVR treated successfully with open and endovascular repair. All patients presented with hypotension, retroperitoneal hematoma, and acute deep vein thrombosis (DVT) causing PLD, with MTS diagnosed intraoperatively.
Results: A 59-year-old woman presented with left leg PLD, hypotension, and pelvic retroperitoneal hematoma. She underwent exploratory laparotomy, which demonstrated a linear tear in her left iliac vein and acute venous thrombus. Narrowing of the left common iliac vein under the right iliac artery was noted and serially dilated. Open embolectomy was performed, with removal of a cast of thrombus from her venous system. The linear tear was repaired primarily. She was anticoagulated and discharged home on day 9. She returned with recurrent left ileofemoral DVT and was treated for definitive therapy of MTS with placement of Wallstents. A 61-year-old woman was transferred for hypotension, acute limb ischemia, and chest pain. A large left-sided pelvic retroperitoneal hematoma and acute DVT throughout her left iliofemoral and popliteal system was found. She was taken for emergent intervention and underwent inferior vena cava filter placement, left iliac vein stenting with Medtronic Endurant limb, and 18-mm Wallstent proximally, and percutaneous mechanical thrombectomy of the popliteal, femoral, and iliac vein. She had an uneventful postoperative course and was discharged home on day 7. Follow-up at 1-year demonstrated patent stents and no post-thrombotic syndrome. A 72-year-old woman was transferred for syncope, shock, left pelvic retroperitoneal hemorrhage, acute iliofemoral and popliteal vein DVT and underwent inferior vena cava filter placement. Despite anticoagulation on day 1, she developed PLD and underwent mechanical pulse-spray thrombectomy, which uncovered a ruptured external iliac vein. This was treated with multiple stent grafts. However, until these were reinforced with 18-mm Wallstents, rethrombosis and residual extravasation remained a problem. She was discharged on day 18 and was asymptomatic at the 1-year follow-up.
Conclusions: SIVR is rare but should be entertained when patients present with the constellation of hypotension, retroperitoneal hematoma, and acute left-sided DVT. This should be treated emergently with either open or endovascular repair with thrombectomy for management of the acute hemorrhage and acute DVT. Definitive treatment should be geared towards treatment of MTS. 
